Enhance your lab operations and funding strategies with actionable advice on equipment leasing, financing, procurement, and life sciences industry trends.
Ansa Biotechnologies secures $54M+ Series B to advance enzymatic DNA synthesis—Excedr covers this major biotech funding round.
October 2025
Cartography Biosciences secures $67M Series B to advance precision cancer immunotherapies—Excedr covers this major biotech funding round.
October 2025
Axon Therapies pioneers a breakthrough in heart failure treatment with splanchnic nerve ablation—Excedr covers this major biotech funding round.
September 2025
Star Therapeutics advances antibody therapies for rare blood disorders—Excedr covers this major biotech funding round.
September 2025
Avenzo Therapeutics raises $60M Series B to advance next-gen cancer therapies—Excedr covers this major biotech funding round announcement.
September 2025